Pennsylvania
Alzheimer's disease clinical trials in Pennsylvania
24 Alzheimer's disease studies are recruiting participants at sites in 5 cities across Pennsylvania as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Browse Pennsylvania by city
Cities with the most studies recruiting right now.
Philadelphia
10 studies recruiting.
Pittsburgh
10 studies recruiting.
Every Pennsylvania city with a recruiting study
Philadelphia (10), Pittsburgh (10), Plymouth Meeting (4), Abington (1), Butler (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Recently updated studies in Pennsylvania
Basic details from each study's public record (the 12 most recently updated of 24). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Phase 3
- Ages 50 to 90
- All sexes
- Sponsor
- Hoffmann-La Roche
- Recruiting in
- Plymouth Meeting
- Registry record
- NCT07177352 · updated
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
- Phase 2
- Ages 55 to 85
- All sexes
- Sponsor
- Sanofi
- Recruiting in
- Plymouth Meeting
- Registry record
- NCT07688213 · updated
ACP-204 in Adults With Alzheimer's Disease Psychosis
- Phase 2/3
- Ages 55 to 95
- All sexes
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Recruiting in
- Abington
- Registry record
- NCT06159673 · updated
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Phase 2
- Ages 55 to 85
- All sexes
- Sponsor
- Eli Lilly and Company
- Recruiting in
- Philadelphia
- Registry record
- NCT07589595 · updated
The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study
- No phase
- Ages 55 to 85
- All sexes
- Sponsor
- California Pacific Medical Center Research Institute
- Recruiting in
- Pittsburgh
- Registry record
- NCT05988385 · updated
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Phase 2
- Ages 50 to 85
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Plymouth Meeting
- Registry record
- NCT07033494 · updated
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Phase 3
- Ages 60 to 85
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Recruiting in
- Plymouth Meeting
- Registry record
- NCT06976203 · updated
Evaluating the Effectiveness of the Health App Recommendation Tool
- No phase
- Ages 18 to 65
- All sexes
- Sponsor
- University of Pittsburgh
- Recruiting in
- Pittsburgh
- Registry record
- NCT07216716 · updated
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Phase 2
- Ages 55 to 90
- All sexes
- Sponsor
- Celgene
- Recruiting in
- Philadelphia
- Registry record
- NCT06808984 · updated
Dominantly Inherited Alzheimer Network (DIAN)
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Washington University School of Medicine
- Recruiting in
- Pittsburgh
- Registry record
- NCT00869817 · updated
PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- University of Pennsylvania
- Recruiting in
- Philadelphia
- Registry record
- NCT05456503 · updated
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
- No phase
- Ages 70 and older
- All sexes
- Sponsor
- University of Michigan
- Recruiting in
- Philadelphia · Pittsburgh
- Registry record
- NCT05929703 · updated
Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Pennsylvania on ClinicalTrials.gov.
Ask about studies in Pennsylvania
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections